Janssen Biotech and Miraca Life Sciences partnered to create “Janssen 2Inform,” a program that provides free therapeutic drug monitoring services to patients with inflammatory bowel disease.
Baton Rouge General, in Louisiana, entered into an agreement with Gastroenterology Associates for the group to provide GI services at the hospital.
The Orlando-based Florida Hospital Center for Interventional Endoscopy has adopted CellvizioSystem, an endomicroscopy diagnostic device developed by the French medical device company Mauna Kea Technologies.
More articles on GI company news:
Janssen Biotech, Miraca Life Sciences partner to create free IBD monitoring services: 5 notes
Gastroenterology Associates to provide GI services for Baton Rouge General: 3 takeaways
Florida Hospital Center for Interventional Endoscopy adopts Cellvizio System: 4 notes
